Gain Therapeutics Appoints Gene Mack as President and Chief Executive Officer, Gianluca Fuggetta as Senior Vice President of Finance
Position
Vice President of Finance
Company
Gain Therapeutics
BethesdaBiotechnologyHealth CareTherapeuticsDescription
Gene Mack, who has served as the company’s Chief Financial Officer and interim CEO, has been appointed President and Chief Executive Officer. Gianluca Fuggetta, the company’s current Finance Vice President, has also been appointed Senior Vice President of Finance and the Company’s Principal Financial Officer.
Quick answer
Gain Therapeutics Appoints Gene Mack as President and Chief Executive Officer, Gianluca Fuggetta as Senior Vice President of Finance (January 10, 2025). Gain Therapeutics is based in Bethesda, Maryland, United States.
- Who is the new Vice President of Finance at Gain Therapeutics?
- Gain Therapeutics named Gianluca Fuggetta Vice President of Finance, announced January 10, 2025.
- What did Gain Therapeutics announce on January 10, 2025?
- Gene Mack, who has served as the company’s Chief Financial Officer and interim CEO, has been appointed President and Chief Executive Officer. Gianluca Fuggetta, the company’s current Finance Vice President, has also been appointed Senior Vice President of Finance and the Company’s Principal Financial Officer.
- What does Gain Therapeutics do?
- Gain Therapeutics, Inc. is a clinical-stage biotechnology company leading the discovery and development of next generation allosteric therapies.
- Where is Gain Therapeutics based?
- Gain Therapeutics is based in Bethesda, Maryland, United States.
- Which similar companies made leadership changes around the same time?
- Pulse Biosciences, Inc. (January 10, 2025), Nimbus Therapeutics (January 9, 2025), Yaqrit (January 10, 2025) and MitoRx Therapeutics (January 9, 2025) also announced leadership changes within 45 days of Gain Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Pulse Biosciences Appoints Paul A. LaViolette as Chief Executive Officer (January 10, 2025)
- Nimbus Therapeutics appoints Peter J. Tummino, Ph.D. as President of Research and Development (January 9, 2025)
- Troels Jordansen Appointed as Chief Executive Officer of Yaqrit, replacing Professor Rajiv Jalan (January 10, 2025)
- MitoRx Therapeutics Appoints Dr. Lubor Gaal as Chief Business Officer and Stacey Massey as Finance Director (January 9, 2025)
- GEMMABio Appoints May Orfali, MD, MBA, as Chief Medical Officer (January 9, 2025)
- Noema Pharma Appoints Michael Samar as Chief Financial Officer and Volker Knappertz as Executive Vice President of Research and Development (January 8, 2025)
Who to call at Gain Therapeutics, and when
A new leader at Gain Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Gain Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Gain Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Gain Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Gain Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Gain Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.